Impromidine was not tested further because the authors noted increases in gastric acid secretion, which was caused by H2R agonists in the stomach, and in cardiac arrhythmias, which are commonly found in connection with cAMP-elevating agents (Felix et al., 1995). The gene discussed is HRH2; the disease is cardiac arrhythmia.